Pharmacoeconomics Past Paper 2018-2019 PDF

# Pharmacy ## Clinical Pharmacy and Therapeutics ### Course Syllabus **Faculty**: Pharmacy **Department**: Clinical Pharmacy and Therapeutics **Academic Year**: 2018-2019 **Semester**: First | Subject Name | Credit Hours | Course No. | Prerequisite | Concurrent course | |---|---|---|---|---| | Ph...

# Pharmacy ## Clinical Pharmacy and Therapeutics ### Course Syllabus **Faculty**: Pharmacy **Department**: Clinical Pharmacy and Therapeutics **Academic Year**: 2018-2019 **Semester**: First | Subject Name | Credit Hours | Course No. | Prerequisite | Concurrent course | |---|---|---|---|---| | Pharmacoeconomics | 2 | 906514 | Pharmacology III (906410) | | | Coordinator Name | Lecturer/s | Room No. | E-mail | Course website | Office Hours | | Dr. Feras Darwish El-Hajji | Dr. Feras Darwish El-Hajji | 4223 | [email protected] | http://bio.asu.edu.jo/bio/index.jsp | | ### Course Description The course starts to serve as an introduction, stressing the importance of the use of pharmacoeconomics to compare costs and outcomes of pharmacy interventions. This course covers the measurement of costs extensively. After that, it discusses the four basic types of pharmacoeconomic research, i.e. cost-minimisation analysis, cost-effectiveness analysis, cost-utility analysis, and cost benefit analysis. All four analyses include the measurement of costs, but differ in the methods used to measure outcomes. As an advanced topic, the course outlines the use of decision analysis methods to model costs and outcomes. ### Course Objectives This course aims to introduce pharmacoeconomics to pharmacy students, and to make them understand the rationale behind studying pharmacoeconomics. Objectives of the course include: 1. Understanding the importance of pharmacoeconomics and its relationship to clinical pharmacy and pharmacy practice 2. Determining the difference between the four most common types of pharmacoeconomics studies. 3. Defining different costing terms, types, and ways of cost calculation. 4. Defining the term quality of life and its importance and applications from a healthcare perception. 5. Understanding the applicability of decision analysis method. ### Intended Learning Outcomes Following the successful completion of this course, the student should be able to: **A. Knowledge and understanding:** * Define pharmacoeconomics. * Understand the importance and clinical relevancy of pharmacoeconomics. * Understand the relationship of pharmacoeconomics to other disciplines. * Describe the differences between the four most common types of pharmacoeconomics studies and their advantages and disadvantages. * Categorize types of costs and sources for obtaining cost data. * Understand when adjusting for timing of costs is appropriate. * List the steps for performing a decision analysis. **B. Subject-Specific Skills:** * Determine the perspective of a study based on types of costs measured. * Compare average costs with marginal or incremental costs. * Discuss the different methods of presenting cost-effectiveness results. * Illustrate the use of a cost-effectiveness grid and a cost- effectiveness plane. * Compare the different methods used in estimating utilities. * Compare the different types of populations used to elicit utility estimates. * Discuss the methods of measuring productivity and intangible costs, including the human capital (HC) and the willingness-to-pay (WTP) approaches. **C. Cognitive and Intellectual Skills:** * Calculate net present value. * Critique pharmacoeconomic research articles. * Compute quality-adjusted life-year (QALY) calculations. * Compare three types of calculation methods used with CBA: net benefits (or net costs), benefit-to-cost (or cost-to-benefit) ratios, and internal rate of return (IRR). **D. Transferable Skills:** * Draw a decision tree. * Calculate average costs and outcomes from a decision tree. * Interpret threshold analysis graphs. ### Teaching and Learning Methods Development of ILOs is promoted through the following teaching and learning methods: | ILOs | Learning Methods | Evaluation Methods | |---|---|---| | A1-A7 | Lectures | Multiple-choice question exams | | B1-B7 | | | | C1, C3-C4 | | | | D1-D3 | | | | C2 | Research article discussion | Exams and open discussion with attending students | ### Course Content | Week | Date | Lecture number/hours | Topic's Details | Exams/quizes | Main Reference (chapter) | ILOs achieved | |---|---|---|---|---|---|---| | 1-2 | | 3 | Introduction to Pharmacoeconomics | - | Chapter 1: Introduction | A1-A4 | | 2-4 | | 4 | Measuring and Estimating Costs | - | Chapter 2: Measuring and Estimating Costs | A5-A6 B1-B2 | | 5 | | 2 | Cost-Minimization Analysis | - | Chapter 4: Cost Minimization Analysis | C1 C2 | | | | | **FIRST EXAM** | | | A4 | | 6-8 | | 5 | Cost-Effectiveness Analysis | - | Chapter 5: Cost-Effectiveness Analysis | B3-B4 C2 | | 8-10 | | 5 | Cost-Utility Analysis | - | Chapter 6: Cost-Utility Analysis | A4 B5-B6 C2-C3 | | | | | **SECOND EXAM** | | | | | 11-12 | | 3 | Cost-Benefit Analysis | - | Chapter 7: Cost-Benefit Analysis | A4 B7 C4 | | 12-15 | | 6 | Decision Analysis | - | Chapter 9: Decision Analysis | A7 D1-D3 | | | | | **FINAL EXAM** | | | | ### Grade Distribution Your course grade will be determined by the following: | Assessment Method | % of Final Grade | Due Date | |---|---|---| | First exam | 25 | To be decided | | Second exam | 25 | To be decided | | Project | 0 | To be decided | | Final exam | 50 | To be decided | **Distribution of examination material (may vary depending on material included):** ### Course Policies **A- Attendance Policies:** * Attendance: Mandatory. * First warning - with 3 absences * Last warning - with 5 absences * Failing in the subject - with 6 absences **B- Absences from exams and handing in assignments on time:** Will result in zero achievement unless health report or other significant excuse is documented. **C- Health and safety procedures:** N/A **D- Honesty policy regarding cheating, plagiarism, misbehavior:** The participation, the commitment of cheating will lead to applying all following penalties together 1. Failing the subject he/she cheated at 2. Failing the other subjects taken in the same course 3. Not allowed to register for the next semester. The summer semester is not considered as a semester **E- Grading policy:** * **Exams and Quizzes.** * First Exam: 25 points * Second Exam: 25 points * Assignments/quizzes: 0 points * Final Exam: 50 points * **Total:** 100 points **F- Available university services that support achievement in the course:** Classroom **Required equipment:** * Data show and internet connection **Make-up Exam Policy:** Make-up exams will be offered for valid reasons. They may be different from regular exams, both in content and format. **Textbooks information:** * **Main Reference:** * Essentials of Pharmacoeconomics, 2nd edition (2014) - Lippincott Williams & Wilkins. Author: Karen Rascati. * **Other References:** * Pharmacoeconomics: Principles and Practice, 1 edition (2012) – SEED Srl. Authors: Pradelli, L., Wertheimer, A. **Additional information:** * No side talks during lecture * No mobile phones during lecture * Entering the lecture theatre after the instructor is not permitted. * Homework should be done by students independently and will be asked at the exams **Course Material and Announcements** * Students need to use the e-learning page at the ASU website in order to get all lecture handouts and guidelines which will be uploaded there. * In addition, course related announcements and exam results will be posted on the e-learning page and is the responsibility of each student to check the site regularly. **Name of Course Coordinator:** *Dr. Feres D. El Hajji* **Signature:** **Date:** 1/14/2018 **Head of curriculum committee:** *Reem Abu Tayeh* **Signature:** **Head of Department:** *Dr. Feras Darwish El Hajji* **Signature:** **Dean:** **Signature:** **Copy to:** - Head of Department - Head of curriculum committee - Course File **Amman - Jordan 5232899 Fax: Tel: 5609999 Form code: UF 130/1 24/233 Resolution number Accreditation date: 31/01/2018**